POTENTIAL ROLE FOR NON-HLA-RESTRICTED CYTOTOXIC-CELLS IN THE IMMUNE SURVEILLANCE OF ACUTE-LEUKEMIA

被引:8
作者
ARCHIMBAUD, E
CAMPOS, L
VILA, L
THOMAS, X
机构
[1] CTR LEON BERARD,INSERM,U218,F-69373 LYON,FRANCE
[2] CTR TRANSFUS SANGUINE,LYON,FRANCE
关键词
ACUTE LEUKEMIA; NATURAL KILLER CELL; LYMPHOKINE-ACTIVATED KILLER CELL; INTERLEUKIN-2; THERAPY; IMMUNE SURVEILLANCE;
D O I
10.1016/0165-2478(93)90158-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The observation of more frequent leukemias in immune deficiencies of the non-HLA-restricted cytotoxic cell system and the participation of this system in the anti-leukemic effect of allogeneic bone marrow transplantation in acute leukemia indicate that these cells might play a role in the immune surveillance against leukemia. In order to find more direct evidence of this role we studied the susceptibility of leukemic cells to lysis by non-HLA-restricted cytotoxic cells, the functional value of these cells in leukemic patients in complete remission (CR), and expression by leukemic cells of adhesion molecules CD54 and CD58, which play a role in the adherence between cytotoxic cells and their targets. Our results are concordant to confirm a potential role of non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia based on increased relapse rate in acute myeloid leukemia patients with no inducible lymphokine-activated killer (LAK) cell activity during CR, short survival of acute lymphoblastic leukemia patients whose blast cells are resistant to lysis by LAK cells, and poor overall prognosis of leukemias which do not express CD58.
引用
收藏
页码:13 / 15
页数:3
相关论文
共 14 条
[1]  
ADLER A, 1988, BLOOD, V71, P709
[2]  
ARCHIMBAUD E, 1991, LEUKEMIA, V5, P967
[3]   INDUCIBILITY OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN COMPLETE REMISSION AND ITS CLINICAL RELEVANCE [J].
ARCHIMBAUD, E ;
BAILLY, M ;
DORE, JF .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (03) :328-334
[4]   SUSCEPTIBILITY OF ACUTE MYELOGENOUS LEUKEMIA BLASTS TO LYSIS BY LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND ITS CLINICAL RELEVANCE [J].
ARCHIMBAUD, E ;
THOMAS, X ;
CAMPOS, L ;
FIERE, D ;
DORE, JF .
LEUKEMIA RESEARCH, 1992, 16 (6-7) :673-680
[5]  
ARCHIMBAUD E, 1992, LEUKEMIA, V6, P265
[6]  
ARCHIMBAUD E, 1992, EXP HEMATOL, V20, P782
[7]   NATURAL-KILLER CELL-ACTIVITY IN HUMAN-BONE MARROW RECIPIENTS - EARLY REAPPEARANCE OF PERIPHERAL NATURAL-KILLER ACTIVITY IN GRAFT VERSUS HOST-DISEASE [J].
DOKHELAR, MC ;
WIELS, J ;
LIPINSKI, M ;
TETAUD, C ;
DEVERGIE, A ;
GLUCKMAN, E ;
TURSZ, T .
TRANSPLANTATION, 1981, 31 (01) :61-65
[8]  
HOROWITZ MM, 1990, BLOOD, V75, P555
[9]  
LOTZOVA E, 1982, EXP HEMATOL, V10, P83
[10]  
MARANINCHI D, 1991, BLOOD, V78, P2182